Join
Live feed
·
INSIDERFilingvia Quantisnow
Sutro Biopharma Inc. logo

CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter bought $13,607 worth of shares (17,000 units at $0.80), increasing direct ownership by 31% to 71,832 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
STRO· Sutro Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STRO (Sutro Biopharma Inc.) and more on Quantisnow.